VSE Corp <VSEC.O>: Jefferies raises target price to $275 from $260
VSEC•Related News
Innate Pharma partners with Sobi to license lacutamab in T-cell lymphoma for USD 75 million upfront
XLV•
Oklo Inc <OKLO.N>: Canaccord Genuity cuts target price to $100 from $125
OKLO•
Lighthouse Canton turns bullish on gold, silver as markets shift from inflation fear to growth fear
GLD•
Howmet Aerospace <HWM.N>: Jefferies raises target price to $370 from $340
HWM•
Albemarle <ALB.N>: RBC cuts target price to $157 from $166
ALB•